Sign in to view content

CD 46 is a Potent Complement Cofactor as Part of a Clinical Strategy for Geographic Atrophy

Thomas A. Ciulla, MD, MBA, FASRS

Video
Published 2026

Related

Baseline Characteristics in the Phase 2 GOLDEN Study of IONIS-FB-LRx, an Investigational Antisense Oligonucleotide Designed to Treat AMD-Associated Geographic Atrophy
Glenn J. Jaffe, MD
Annual Meeting Talks
2022
Early vs Delayed Pegcetacoplan Treatment for GA Secondary to AMD: 48-Month Results From OAKS, DERBY,and GALE Open-Label Extension
Roger A. Goldberg, MD, MBA
Annual Meeting Talks
2025
Inhibition of C1q Protects Photoreceptor Synapses in a Light Damage Model and Is a Potential Treatment for Geographic Atrophy
Patrick Dewey Williams, MD
Annual Meeting Talks
2022

Category: Age-Related Macular Degeneration

See more